Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

seqwel Steve Smith

seqWell makes five new appointments

, 18 November 2021/in E-News /by panglobal

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell multiplexing platform, announced five appointments to its commercial team. Led by Steve Smith, who joins as Chief Commercial Officer, the team will be responsible for driving awareness, adoption, and development of the plexWell platform and product pipeline, to provide scientists […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/seqwel_Steve-Smith.jpg 2190 2028 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:50:032021-11-18 12:50:03seqWell makes five new appointments
saga diagnostics

SAGA Diagnostics enters into assay development agreement with AstraZeneca

, 18 November 2021/in E-News /by panglobal

SAGA Diagnostics, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with AstraZeneca, the global biopharmaceutical company.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/saga-diagnostics.png 470 502 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:48:082021-11-18 12:48:08SAGA Diagnostics enters into assay development agreement with AstraZeneca
Heiner Dreismann

Heiner Dreismann joins Noscendo’s Board of Directors

, 18 November 2021/in E-News /by panglobal

Noscendo, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections has appointed Heiner Dreismann, former President and CEO of Roche Molecular Systems, to its Board of Directors.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/Heiner-Dreismann-scaled.jpg 2560 1707 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:36:582021-11-18 12:38:52Heiner Dreismann joins Noscendo’s Board of Directors
Mogrify Tom Graney

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

, 18 November 2021/in E-News /by panglobal

Mogrify, a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, has appointed Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He joins senior biopharma industry executives, Dr. Jane Osbourn OBE (Chair) and Dr. Lorenz Mayr, as […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/Mogrify_Tom-Graney_-scaled.jpg 1344 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:33:522021-11-18 12:33:52Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor
dotmatics logo

Dotmatics partners with RockStep Solutions to provide integrated solution for digitalized in vivo drug discovery

, 18 November 2021/in E-News /by panglobal

Dotmatics, a science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, announced a partnership with RockStep Solutions, a developer of software tools for managing data and operations for in vivo research. The collaboration combines the simple, unified, realtime access to all research data […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/dotmatics-logo.jpg 512 2000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:32:102021-11-18 12:32:10Dotmatics partners with RockStep Solutions to provide integrated solution for digitalized in vivo drug discovery
dna

BioNet and BIA Separations collaborate on production process development of mRNA vaccines

, 18 November 2021/in E-News /by panglobal

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/dna-scaled.jpg 1280 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:30:132021-11-18 12:30:13BioNet and BIA Separations collaborate on production process development of mRNA vaccines
BIOFORTUNA

Biofortuna doubles their manufacturing space to meet demand

, 18 November 2021/in E-News /by panglobal

Biofortuna, a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/BIOFORTUNA.jpg 794 1598 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:27:552021-11-18 12:27:55Biofortuna doubles their manufacturing space to meet demand
aragen

Aragen expects to ride wave of US biotech growth in 2022 on back of demand for CDMO services

, 18 November 2021/in E-News /by panglobal

Hyderabad, India-based Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at around 40% year-on-year.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/aragen.jpg 547 690 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:25:472021-11-18 12:25:47Aragen expects to ride wave of US biotech growth in 2022 on back of demand for CDMO services
truemass logo

True Mass presents first commercial CDMS instrument to support analysis of macromolecules

, 18 November 2021/in E-News /by panglobal

TrueMass presented the world’s first commercially designed charge detection mass spectrometer (CDMS) at this year’s American Society of Mass Spectrometry conference in Philadelphia, PA, early November.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/truemass_logo.png 214 678 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-18 12:23:252021-11-18 12:23:25True Mass presents first commercial CDMS instrument to support analysis of macromolecules
accelerating med

NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases

, 3 November 2021/in E-News /by 3wmedia

The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/accelerating-med.png 1158 1138 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-11-03 10:16:512021-11-03 10:16:51NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases
Page 60 of 228«‹5859606162›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription